The Results Regarding Clinical Trials of Domestic Vaccine Turkovac were Published.
The results regarding Phase 1, Phase 2, Phase 2B and Phase 3 clinical trials of TURKOVAC, which is Turkey's only and one of the nine COVID-19 vaccines in the world; was developed with the support and coordination of TÜSEB in cooperation with Erciyes University; and are successfully carried out with more than 1000 researchers in 41 centres and 28 cities, were published.
The information on publications containing detailed scientific data on the results of Turkovac’s protection, immune responses, time-dependent effects etc. are given below.
“Safety and immunogenicity of an inactivated whole virion SARS-CoV-2 vaccine, TURKOVAC, in healthy adults: interim results from randomised, double-blind, placebo-controlled phase 1 and 2 trials” titled publication containing the results of Phase 1 and Phase 2 was published on “Vaccines” journal. Click here to access web page.
